AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A high index level often signals stronger market momentum or potential overbought conditions. Grasp its implications to adjust exposure and risk.
25,535 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A new nationwide survey finds 39% of Americans store unused electronics in drawers, while only 10% are recycled or re...
GL Homes’ Riverland community demonstrates how interconnected design and amenities sustain sales momentum in a rising...
Berkshire Hathaway disclosed a new stake in Macy’s in its Q1 2026 13F, a small starter position that contrasts with p...
A Solvang, California property once linked to Dolly Parton is back on the market for about $2 million, boasting a win...
Spotify faces a pivotal 2026-2028 window as earnings beat meet guarded guidance. This piece breaks down where Spotify...
Entrepreneurship powered America’s rise, and Steve Case argues we must expand that engine nationwide to guard the cou...
When MoonLake Immunotherapeutics announced a larger-than-expected secondary offering, the stock wilted. This guide br...
Investors are eyeing a potential rebound for Figma as enterprise adoption grows and AI-driven updates sharpen the pla...
NVIDIA delivered a blockbuster quarter while Cerebras reported explosive inference speed that still risks negative ma...
Steve Eisman, famed for predicting the housing crash, weighs in on the AI stock rally, warning that hype outpaces ear...
Paris Saint-Germain is testing a global lifestyle brand built on the idea that a football club can be more than its s...